Marker Therapeutics, Inc.

Tagged: peter hoang

Marker Therapeutics Announces Change in Corporate Headquarters and Access to New Laboratory Facility

Marker Therapeutics has formally relocated their corporate headquarters from Jacksonville, Florida to Houston, Texas. In addition, the Company has announced that it is now a resident company at Johnson & Johnson Innovation – JLABS (JLABS at TMC).

Read More

Marker Therapeutics to Present at the 2019 BIO CEO & Investor Conference

Chief Financial Officer, Anthony H. Kim, to present a corporate overview at the upcoming BIO CEO & Investor Conference on Monday, February 11, 2019.

Read More

Marker Therapeutics to Present at the Phacilitate Leaders World & World Stem Cell Summit 2019

Peter L. Hoang to present a corporate overview at the upcoming Phacilitate Leaders World & World Stem Cell Summit 2019 on January 23, 2019.

Read More

Marker Therapeutics to Present at the Tumor Targeted Lymphocytes Summit

President and CEO, Peter L. Hoang, will be participating at the Tumor Targeted Lymphocyte Summit.

Read More

TapImmune to Present at 2018 NYC Oncology Investor Conference

TapImmune President & CEO, Peter Hoang, will be giving a company presentation at the 2018 NYC Oncology Investor
Conference on May 9th at 3:00pm ET.

Read More

TapImmune to Present at 2018 Disruptive Growth & Healthcare Conference

TapImmune President & CEO, Peter Hoang, will be participating in a panel discussion and give a company presentation at the 2018 Disruptive Growth & Healthcare Conference on May 9th.

Read More

TapImmune Provides Fourth Quarter and Year-End 2017 Corporate and Clinical Update

Please join us for our fourth quarterly call and year end update of 2017 today, April 5, 2018, 4:30pm ET.

Read More

TapImmune to Provide Fourth Quarter and Full Year 2017 Business Update Conference Call and Webcast

Please join us for our fourth quarterly call and year end update of 2017 on April 5, 2018 at 4:30pm.

Read More

TapImmune to Present at The MicroCap Conference

TapImmune President and CEO, Peter Hoang, to present at 2018 The Microcap Conference.

Read More

TapImmune to Participate in Two Upcoming Investor Conferences

TapImmune President & CEO, Peter Hoang, will be participating in two conferences in the upcoming weeks.

Read More